AstraZeneca PLC
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AZNL.XC | PFE | MRK | NVS | GLAXO.NS | LLY.NE | |
|---|---|---|---|---|---|---|
| Market cap | 219.94B | 175.50B | 370.96B | 311.59B | 423.55B | 1.74T |
| P/E (TTM) | 26.8 | 44.0 | 151.9 | 31.5 | 36.9 | 65.7 |
| Forward P/E | — | 10.6 | 16.7 | 16.6 | 31.6 | — |
| Price/book | 5.7 | 2.1 | 8.9 | 8.4 | 22.5 | 1.4 |
| Dividend yield | 1.70% | 5.59% | 2.26% | 2.87% | 2.25% | 0.58% |
| 1-year change | +9.66% | +23.90% | +75.29% | +30.35% | −2.83% | +35.37% |
| Today | +0.57% | +2.63% | +3.93% | +3.59% | −1.25% | +0.78% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All AZNL.XC news ›AstraZeneca (AZN) Stock Climbs 3% as $10 Billion Rhythm Bid Report Surfaces
Rhythm Pharmaceuticals (RYTM) jumped 28% to close at $110.68 on Wednesday. The move came after reports that AstraZeneca (AZN) wants to buy the company. AstraZeneca stock also moved higher, gaining about 3% on the day. Its market value…
AstraZeneca makes $10 billion offer for obesity drugmaker Rhythm, WSJ reports
- AstraZeneca is reaching for a niche corner of the obesity boom, and paying a premium to get there. AstraZeneca has made an offer of around $10 billion for Rhythm Pharmaceuticals, The Wall Street Journal reported, citing people familiar…
AstraZeneca made a $10bn offer to buy Rhythm Pharmaceuticals
AstraZeneca has made an offer to acquire Boston-based Rhythm Pharmaceuticals, a laboratory specializing in obesity treatments, according to the Wall Street Journal. This announcement made Rhythm's stock surge 28% to $110.6. Published on…
AstraZeneca appoints Naveen Krishna Yamarthi as Managing Director, AstraZeneca India Private Limited (AZIPL) and Head of Global Innovation & Technology Centre, Chennai
Chennai, 04 November 2026: AstraZeneca announced the appointment of Naveen Krishna Yamarthi as Managing Director AZIPL and Head of its Global Innovation & Technology Centre (GITC), Chennai, effective 30 October 2026. In this role, Naveen…
AstraZeneca Weighs Roughly $10 Billion Takeover of Rhythm Pharmaceuticals, Sending Shares Up 28%
AstraZeneca has floated an offer of roughly $10 billion for Rhythm Pharmaceuticals, the rare-disease and obesity drug developer, according to three people with knowledge of the matter, a move that would deepen the British drugmaker's…
AstraZeneca drops EU bid for Truqap in hormone-sensitive PTEN-deficient prostate cancer
AllSci AstraZeneca has withdrawn its application with the European Medicines Agency (EMA) to extend capivasertib (Truqap) to newly diagnosed metastatic PTEN-deficient hormone-sensitive prostate cancer after the C
AstraZeneca Filing Accepted in Europe and Japan for Lung Cancer
AstraZeneca’s regulatory filings for a TAGRISSO and ORPATHYS combination have been accepted in Europe and Japan for a form of non-small cell lung cancer. The… AstraZeneca (LSE:AZN) said its filings for the TAGRISSO plus ORPATHYS regimen…
RYTM Stock Clocks Best Day In Nearly 16 Months On AstraZeneca $10B Bid Report
Shares of Rhythm Pharmaceuticals (RYTM) closed up 28% on Wednesday, clocking its best day since July 2025, following reports that U.K-based pharma giant AstraZeneca had submitted a roughly $10 billion takeover proposal for it. According to…
Why Did AstraZeneca (LSE:AZN) Stock Jump After Its Cost-Savings Reset This Week?
Ecora Royalties (LSE:ECOR) Gets Cobalt Boost Below FTSE 100 Vanquis (LSE:VANQ) Rebuilds Returns Below the FTSE 100 Big Technologies (LSE:BIG) Braces for a Legal Fight Raspberry Pi (LSE:RPI) Founder Buys In Below the FTSE 100 The…
AstraZeneca Submits $10 Billion Takeover Offer for Rhythm Pharmaceuticals
AstraZeneca offered $124 per share to take over biotechnology company Rhythm Pharmaceuticals, The Wall Street Journal reported Wednesday, citing people familiar with the matter. The unnamed... AstraZeneca Submits $10 Billion Takeover Offer…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com85
- tradingview.com12
- seekingalpha.com10
- statnews.com8
- defenseworld.net7
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.